Corcept Therapeutics CORT Q1 2026 Earnings Severe Earnings Miss Overshadows Operational Developments Regal Rexnord RRX Q1 2026 Earnings Adjusted EPS Tops Estimates Shares Edge Higher UTI Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense RWTN Q1 2026 Earnings EPS Falls Short of Estimates but Shares Edge Higher TTWO Q1 2026 Earnings Strong EPS Beat Fails to Lift Shares